openPR Logo
Press release

Carotid Artery Disease Market Research 2018: Causes, Treatment and Management Prospective-Will Emphasize Human Factors in Healthcare

12-10-2018 07:14 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Market Research Future

Carotid Artery Disease Market Research 2018: Causes, Treatment

Global Carotid Artery Disease Market is expected to witness positive growth during the forecast period. The rising prevalence of cardiovascular diseases, rising incidences of stroke, increased adoption of technologically advanced devices, rising incidence of hypertension, diabetes, and others, growing obesity, smoking, and alcohol consumption, increasing geriatric population, and growing healthcare sector are the key factors for the market to grow.

However, factors such as high cost of diagnostics and surgeries, huge initial investments, associated risks of cardiovascular drugs, and surgeries are expected to restrict the market growth during the forecast period.

Some of the key players for the global carotid artery disease market are Cordis Corporation (US), Medtronic (US), Silk Road Medical Inc. (US), InspireMD Inc., Boston Scientific Corporation (US), C.R. Bard, Inc. (US), Cook Medical (US) and W.L. Gore & Associates (US) and Abbott Vascular, Inc. (US), and others.

Avail Sample Copy for this Report at https://www.marketresearchfuture.com/sample_request/6301

The global carotid artery disease market is segmented on the basis of diagnosis, treatment, and end-user. The diagnosis category includes physical exam, computed tomography angiography, carotid angiography, magnetic resonance angiography, and carotid ultrasound.

The treatment segment is further segmented into medications and surgical procedures. The medications category includes aspirin, clopidogrel, and others. Surgical procedures are categorized into carotid endarterectomy, carotid artery angioplasty, and carotid artery stenting.

On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, pharmacies, and others.

Regional Analysis

The Americas is expected to dominate the carotid artery disease market during the forecast period. The increasing incidence of cardiovascular diseases drives the market in this region. As per the Centers for Disease Control and Prevention 2015, one in four people dies due to cardiovascular disease in the US. This influences the market growth during the forecast period. The growing geriatric population and technological advancements drive the market growth in this region.

Europe (UK, Belgium, France, and Netherlands) is the second largest in the market owing to the increasing prevalence of high blood pressure within this region. According to the European Society of Hypertension and the European Society of Cardiology, 30 to 45% people in Europe suffer from hypertension. Thus, the increasing prevalence of hypertension in this region influences the growth of this market in this region.

Asia-Pacific is expected to observe growth for the global carotid artery disease market owing to the increasing prevalence of diabetes, rising geriatric population, and change to an unhealthy lifestyle.

The Asian Diabetes Prevention Initiative projected that India and China will have a total of half billion diabetic patient pool by 2030, thus, providing favorable backgrounds for the market to grow.

The Middle East and Africa accounts for least share due to stringent government policies, low investments in the healthcare sector, and poor economies. However, the developing healthcare sector along with several government initiatives may lead to market growth during the forecast period.

Browse Complete Research Report at https://www.marketresearchfuture.com/reports/carotid-artery-disease-market-6301

Other key factors such as rising blood fat levels among the population, increasing geriatric population, growing prevalence of diabetes, increasing obesity, growing number of high blood pressure patients, and sedentary lifestyle are contributing towards the growth of the market.

Intended Audience

Pharmaceutical companies
Biotechnological institutes
Government and private laboratories
Research and Development (R&D) companies
Medical research laboratories
Market research and consulting service providers

Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6301

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carotid Artery Disease Market Research 2018: Causes, Treatment and Management Prospective-Will Emphasize Human Factors in Healthcare here

News-ID: 1429880 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and